Pathogenesis of Autoimmune Diseases in Large Granular Lymphocyte Leukemia

References

• Timonen, T., Ortaldo, J. R. and Herberman, R. B (1981). Characteristics of human large granular lymphocytes and relationship to natural killer and K cells, J. Exp. Med., 153, 569–582.
   PubMed Web of Science ®Google Scholar
• Lanier, L. L., Phillips, J. H., Hackett, J. Jr., Tutt, M. and Kumar, V. (1986). Natural killer cells: definition of a cell type rather than a function. J. Immunol., 137, 2735–2739.
   PubMed Web of Science ®Google Scholar
• Mc Kenna, R. W., Parkin, J., Kersey, J. H., Gajl-Peczalska, K. J., Peterson, L. and Brunning, R. D. (1977). Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics, Am. J. Med., 62, 588–596.
   PubMed Web of Science ®Google Scholar
• Dhodapkar, M. V., Li, C. Y., Lust, J. A., Tefferi, A. and Phyliky, R. L. (1994). Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?, Blood, 1620–1627.
   Google Scholar
• Semenzato, G., Pandolfi, F., Chiesesi, T., De Rossi, G., Pizzolo, G., Zambello, R., Trentin, L., Agostini, C., Dini, E., Vespignani, M., Cafaro, A., Paqualetti, D., Giubellino, M. C., Mignole, N. and Foa, R. (1987). The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions, Cancer, 60, 2917–2978.
   Web of Science ®Google Scholar
• Oshimi, K., Yamada, O., Kanako, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, T., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Togawa, A., Masuda, Y., Okubo, Y., Furusawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. and Mizoguchi, H. (1993). Laboratory findings and clinical courses of 33 patients with large granular lymphocyte proliferative disorders, Leukemia, 7, 782–788.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr. (1993). Clonal diseases of large granular lymphocytes, Blood, 82, 1–4.
   PubMed Web of Science ®Google Scholar
• Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B. and Gatter, K. C. (1994). A revised European American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group, Blood, 84, 1361–1392.
   PubMed Web of Science ®Google Scholar
• Gentile, T. C., Uner, A. H., Hutchinson, R. E., Wright, J., Ben-Ezra, J., Russel, E. C. and Loughran, T. P. Jr. (1994). CD3+ CD56+ aggressive variant of large granular lymphocyte leukemia, Blood, 84, 2315–2321.
   PubMed Web of Science ®Google Scholar
• Morikawa, K., Oseko, F., Hara, J., Kobayashi, S., Nakano, A. and Morikawa, S. (1990). Functional analysis of clonally expanded CD8, TCRγδ T cells in a patient with chronic T-gamma lymphoproliferative disease, Leuk. Res., 14, 581–592.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P., Starkebaum, G., Kidd, P. and Neiman, P. (1988). Clonal proliferation of large granular lymphocytes in rheumatoid arthritis, Arthritis Rheum., 31, 31–36.
   PubMed Web of Science ®Google Scholar
• Fernandez, L. A., Pope, B., Lee, C. and Zahed, E. (1986). Aggressive natural killer cells leukemia in an adult with establishment of an NK cell line, Blood, 67, 925–930.
   PubMed Web of Science ®Google Scholar
• Taniwaki, M., Tagawa, S., Nishigaki, H., Horiike, S., Misawa, S., Shimazaki, C., Maekawa, T., Fujii, H., Kitani, T. and Abe, T. (1990). Chromosomal abnormalities define clonal proliferation in CD3- large number granular lymphocyte leukemia, Am. J. Hematol., 33, 32–38.
   PubMed Web of Science ®Google Scholar
• Kwong, Y. L., Wong, K. F., Chan, L. C., Liang, R. H., Chan, J. K., Lin, C. K. and Chan, T. K. (1995). Large granular lymphocyte leukemia: A study of nine cases in a Chinese population, Am. J. Clin. Pathol., 103, 76–81.
   PubMed Web of Science ®Google Scholar
• Bassan, R., Pronesti, M., Buzzetti, M., Allavena, P., Rambaldi, A., Mantovani, A. and Barbui, T. (1989). Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells, Cancer, 63, 90–95.
   PubMed Web of Science ®Google Scholar
• Gentile, T. C., Wener, M. H., Starkebaum, G. and Loughran, T. P. Jr. (1996). Humoral immune abnormalities in T-cell large granular lymphocyte leukemia, Leuk. Lymphoma., 23, 365–370.
   PubMed Web of Science ®Google Scholar
• Hanada, T., Ishida, T., Kojima, H. and Tsuchiya, T. (1992). Granular lymphocyte leukemia in association with multiple myeloma, Br. J. Haematol., 80, 127–129.
   PubMed Web of Science ®Google Scholar
• Lauria, F., Fao, R., Mogone, N., Giubellino, M. C., Rasparodi, D., Buzzi, M., Casorati, G., Gobbi, M., Tazzari, P. L. and Tura, S. (1978). Heterogeneity of large granular lymphocyte proliferations: morphological, immunological, and molecular analysis in seven patients, Br. J. Haematol., 66, 187–191.
   Web of Science ®Google Scholar
• Kaneko, T., Ogawa, Y., Hirata, Y., Hoshino, S., Takahashi, M., Oshimi, K. and Mizogichi, H. (1990). Agranulocytosis associated with granular lymphocyte leukemia: improvement of peripheral blood granulocyte count with huma recombinant granulocyte colony-stimulating factor (G-CSF), Br. J. Haematol., 74, 121–122.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr., Clark, E. A., Starkebaum, G., Kidd, P. and Clark, C. A. (1987). Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2, Blood, 69, 72–78.
   PubMed Web of Science ®Google Scholar
• Oshimi, K. (1988). Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature, Leukemia, 2, 617–627.
   PubMed Web of Science ®Google Scholar
• Hoshino, S., Oshimi, K., Teramura, M. and Mizoguchi, H. (1991). Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders, Blood, 78, 3232–3240.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr., Aprile, J. A. and Ruscetti, F. W. (1990). Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2 independent pathway in CD3+ large granular lymphocytes, Blood, 75, 935–940.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr. and Starkebaum, G. (1987). Large granular lymphocyte leukemia: report of 38 cases and review of the literature, Medicine, 66, 397–405.
   PubMed Web of Science ®Google Scholar
• Morley, J. K., Batliwalla, F. M., Hinorani, R. and Gregersen, P. K. (1995). Oligoclonal CD8+T cells are preferentially expanded in the CD57+ subset, J. Immunol., 154, 6182–6190.
   PubMed Web of Science ®Google Scholar
• Posnett, D. N., Sinha, R., Kabak, S. and Russo, C. (1994). Clonal populations of T cells in normal elderly humans: the T cells equivalent to benign monoclonal gammapathy, J. Exp. Med., 179, 609–618.
   PubMed Web of Science ®Google Scholar
• Sottini, A., Bettinardi, A., Quiros-Roldan, E., Plebani, A., Airo, P., Primi, D. and Imberti, L. (1995). Evidence for antigenic selection of large granular lymphocytes in a patient with Wiskott-Aldrich syndrome, Blood, 86, 2240–2247.
   PubMed Web of Science ®Google Scholar
• Davey, M. P., Starkebaum, G. and Loughran, T. P. Jr. (1995). CD3+ leukemic large granular lymphocytes utilize diverse T-cell receptor Vβ genes, Blood, 85, 146–150.
   PubMed Web of Science ®Google Scholar
• Zambello, R., Trentin, L., Facco, M., Cerutti, A., Sancetta, R., Milani, A., Raimondi, R., Tassinari, C., Agostini, C. and Semanzato, G. (1995). Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: superantigen activation of clonal CD3+ granular lymphocytes, Cancer Research, 55, 6140–6145.
   PubMed Web of Science ®Google Scholar
• Kasten-Sportes, C., Zaknoen, S., Streis, R. G., Chan, W. C., Winton, E. F. and Waldmann, T. A. (1994). T-cell receptor gene rearrangement in T-cell large granular leucocyte leukemia: preferential Vα but diverse Jα usage in one of five patients, Blood, 83, 767–775.
   PubMed Web of Science ®Google Scholar
• Jenkins, R. N. and McGinnis, D. E. (1995). T-cell receptor Vβ gene utilization in rheumatoid arthritis and multiple sclerosis, Ann. NY. Acad. Sci., 756, 159–172.
   PubMed Web of Science ®Google Scholar
• Bach, J. F. (1995). T-cell receptor use in organ-specific human auto-immune diseases other than rheumatoid arthritis and multiple sclerosis, Ann. NY. Acad. Sci., 756, 453–459.
   PubMed Web of Science ®Google Scholar
• Gorochov, G., Debre, P., Leblond, V., Sadat-Souti, B., Sigaux, F. and Autran, B. (1994). Oliglonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor β chain variability after bone marrow transplantation, Blood, 83, 587–595.
   PubMed Web of Science ®Google Scholar
• Wucherpfenning, K. W., Weiner, H. L. and Halfer, D. A. (1991). T-cell recognition of myelin basic protein, Immunol. Today, 12, 277–282.
   PubMedGoogle Scholar
• Dolstra, H., Preijers, F., Van de Wiehl-Van Kemenade, E., Schattenberg, A., Galama, J. and De Witte, T. (1995). Expansion of CD8+ CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection, Br. J. Haematol., 90, 300–307.
   PubMed Web of Science ®Google Scholar
• Dupuy D Angeac, A., Monier, S., Jorgensen, C., Gao, Q., Travaglio-Encinoza, A., Bologna, C., Combe, B., Sany, J. and Reme, T. (1993). Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis: correlation with duration of disease, Arthritis Rheum., 36, 608–612.
   PubMed Web of Science ®Google Scholar
• Marlton, P., Taylor, K., Elliott, S. and McCormack, J. (1992). Monoclonal large granular lymohocyte proliferation in SLE with HTLV-I seroreactivity, Aust. N. Z. J. Med., 22, 54–55.
   PubMedGoogle Scholar
• Molitor, J. L., saint-Louis, J., Louvet, C., Vachon, A., Vincent, L. and Beaulieu, R. (1997). Large granular lymphocytic leukemia disclosed by bilateral uveitis: association with celiac disease, Rev. Med. Interne., 18, 237–239.
   PubMed Web of Science ®Google Scholar
• Hingorani, R., Monteiro, J., Pergolizzi, R., Furie, R., Chartash, E. and Gregersen, P. K. (1995). CDR3 length restriction of T-cel receptor beta; chains in CD8+ T-cells of rheumatoid arthritis patients, Am. NY. Acad. Sci., 756, 179–182.
   PubMed Web of Science ®Google Scholar
• Der Simonian, H., Sugita, M., Glass, D. N., Maier, A. L., Weinblatt, M. E., Reme, T. and Brenner, M. B. (1993). Clonal Vα 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients, J. Exp. Med., 177, 1623–1631.
   PubMed Web of Science ®Google Scholar
• Imberti, L., Sottini, A., Signorini, S., Gorla, R. and Primi, D. (1997). Oligoclonal CD4+CD57+ T-cell expansions contribute to the inbalanced T-cell receptor repertoire of rheumatoid arthritis patients, Blood, 89, 2822–2832.
   PubMed Web of Science ®Google Scholar
• Quiros-Roldan, E., Sottini, A., Gulletta, M., Stellini, R., Puoti, M., Primi, D. and Imberti, L. (1996). The T-cell receptor repertoires expressed by CD4+ and CD4—large granular lymphocytes derived from the same patients suggest the persistent action of an immune-mediated selection process, Blood, 88, 2133–2143.
   PubMed Web of Science ®Google Scholar
• Burns, C. M., Tsai, V. and Zvaifler, N. J. (1992). High percentage of CD8+, Leu7+ cells in rheumatoid arthritis synovial fluid, Arthritis Rheum., 35, 865–873.
   PubMed Web of Science ®Google Scholar
• Gonzales-Chambers, R., Przepiorka, D., Winkelstein, A., Agarwal, A., Starz, T. W., Kline, W. E. and Hawk, H. (1992). Lymphocyte subsets associated with T cell receptor β-chain gene rearrangement in patients with rheumatoid arthritis and neutropenia, Arthritis Rheum., 35, 516–520.
   PubMed Web of Science ®Google Scholar
• Wallis, W. J., Loughran, T. P. Jr., Kadin, M. E., Clark, E. A. and Starkebaum, G. A. (1985). Polyarthritis and neutropenia associated with circulating large granular lymphocytes, Ann. Inter. Med., 103, 357–362.
   PubMed Web of Science ®Google Scholar
• Kuipers, J. G., Jacobs, R., Kemper, A., Zeidler, H. and Schmidt, R. E. (1994). TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis, Rheumatol. Int., 14, 163–168.
   PubMed Web of Science ®Google Scholar
• Bowman, S. J., Sivakumaran, M., Snowden, N., Bhavnani, M., Hall, M. A., Panayi, G. S. and Lanchbury, J. S. (1994). The large granular lymphocyte syndrome with rheumatoid arthritis, Immunogenetic evidence of a broader definition of Felly's syndrome, Arthritis Rheum., 37, 1326–1330.
   PubMed Web of Science ®Google Scholar
• Snowden, N., Bhavnani, M. and Swinson, D. R. (1991). Large granular T lymphocytes, neutropenia and polyarthropathy: an underdiagnosed syndrome?, Q. J. Med., 78, 65–76.
   PubMedGoogle Scholar
• Bowman, S. J., Corrigall, V., Panayi, G. S. and Lanchbury, J. S. (1995). Hematologic and cytofluoro-graphic analysis of patients with Felty's syndrome: a hypothesis that a discrete event leads to large granular lymphocyte expansions in this condition, Arthritis Rheum., 38, 1252–1259.
   PubMed Web of Science ®Google Scholar
• Starkebaum, G., Loughran, T. P., Gaur, L. K., Davis, P. and Nepom, B. S. (1997). Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis, Arthritis Rheum., 40, 624–626.
   PubMed Web of Science ®Google Scholar
• Sampalo, L. A., Lopez-Gomez, M. and Jimenez-Alonso, J. (1995). Proliferation of large granular lymphocytes in patients with systemic lupus erythematosus, Rev. Clin. Esp., 195, 373–379.
   PubMed Web of Science ®Google Scholar
• Sanchez, B. J., Grana, G. J., Cadorniga, E., Alvarz, A. and Galdo, F. F. (1989). Sicca syndrome caused by large granular lymphocytes in rheumatoid arthritis, Med. Clin.(Barc), 93, 741–742.
   PubMed Web of Science ®Google Scholar
• Dhodapkar, M. V., Lust, J. A. and Phyliky, R. L. (1994). T-cell large granular lymphocytic leukemia and pure red cell aplasia in patient with type I autoimmune polyendocrinopathy: response to immunosuppressive therapy, Mayo. Clin. Proc., 69, 1085–1088.
   PubMed Web of Science ®Google Scholar
• Rodriguez, A., Yood, R. A., Condon, T. J. and Foster, C. S. (1997). Recurrent uveitis in a patient with adult onset cyclic neutropenia associated with increased large granular lymphocytes, Br. J. Ophtalmol., 81, 415.
   PubMed Web of Science ®Google Scholar
• Erslev, A. J. and Soltan, A. (1996). Pure red-cell aplasia: a review, Blood Rev., 10, 20–28.
   PubMed Web of Science ®Google Scholar
• Charles, R. J., Sabo, K. M., Kidd, P. G. and Abkowitz, J. L. (1996). The pathophysiology of pure red cell aplasia: implications for therapy, Blood, 87, 4831–1838.
   PubMed Web of Science ®Google Scholar
• Lacy, M. Q., Kurtin, P. J. and Tefferi, A. (1996). Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities, Blood, 87, 3000–3006.
   PubMed Web of Science ®Google Scholar
• Motoji, T., Yamada, O., Takahashi, M., Oshimi, K. and Mizoguchi, H. (1992). A case of granular lymphocyte leukemia with pure red cell aplasia: the usefulness of gene analysis in assessing therapeutic effect, Am. J. Hematol., 39, 212–219.
   PubMed Web of Science ®Google Scholar
• Levitt, L. J., Reyes, G. R., Moonka, D. K., Bensch, K., Miller, R. A. and Engleman, E. G. (1988). Human T cell leukemia virus-I associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease, J. Clin. Invest., 81, 538–548.
   PubMed Web of Science ®Google Scholar
• Hoffman, R., Kopel, S., Hsu, S. D., Darniack, N. and Zanjani, E. D. (1978). T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoeisis in vitro, Blood, 52, 255–260.
   PubMed Web of Science ®Google Scholar
• Hara, T., Mizuno, Y., Nagata, M., Okabe, Y., Taniguchi, S., Harada, M., Niho, Y., Oshimi, K., Ohga, S., Yoshikai, Y., Nomoto, K., Yumura, K., Kawa-Ha, K. and Ueda, K. (1990). Human γδ T-cell receptor-positive cell-mediated inhibition of erythropoeisis in vitro in patient with type I autoimmune polyglandular syndrome and pure red cell aplasia, Blood, 75, 941–950.
   PubMed Web of Science ®Google Scholar
• Means, R. J. and Krantz, S. B. (1992). Progress in understanding the pathogenesis of the anemia of chronic disease, Blood, 80, 1639–1647.
   PubMed Web of Science ®Google Scholar
• Yamada, O., Mizoguchi, H. and Oshimi, K. (1997). Cyclophosphamide therapy for pure cell aplasia associated with granular lymphocyte-proliferative disorders, Br. J. Haematol., 97, 392–399.
   PubMed Web of Science ®Google Scholar
• Matrai, Z., Lelkes, G., Milosevits, J., Paldine, H. P. and Pecze, K. (1997). T-cell large granular lymphocytic leukemia associated with red cell aplasia, sucessfully treated with cyclophosphamide, Orv. Hetil., 138, 2075–2080.
   PubMedGoogle Scholar
• Kouides, P. A. and Rowe, J. M. (1995). Large granular lymphocyte leukemia presenting with both amegakaryocytic thrombocytopenic purpura and pure red cell aplasia, Am. J. Hematol., 49, 232–236.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P., Marshall, E., Kadin, M. E., Starkebaum, G., Abkowitz, J. L., Clark, E. A., Disteche, C., Lum, L. G. and Slichter, J. (1985). Leukemia of large granular lymphocytes: Association with clonal chromosomal abnormalities and auto-immune neutropenia, thrombocytopenia and hemolytic anemia, Ann. Intern. Med., 102, 169–175.
   PubMed Web of Science ®Google Scholar
• Gentile, T. C. and Loughran, T. P. (1996). Resolution of autoimmune hemolytic anemia following splenectomy in CD3+ large granular lymphocyte leukemia, Leuk. lymphoma., 23, 405–408.
   PubMed Web of Science ®Google Scholar
• Van der Veen, J. P. W., Goldschmeding, R., Miedema, F., Smit, J. W., Melief, C. J. M. and von Dem Borne, A. E. G. Kr. (1986). K-cell lymphocytosis/neutropenia syndrome: the neutrolpenia is not caused by autoimmunity, Br. J. Haematol., 64, 77–78.
   PubMed Web of Science ®Google Scholar
• Linch, D. C., Newland, A. C., Turnbull, A. L., Knott, L. J., MacWhannel, A. and Beverley, P. (1984). Unusual T cell proliferations and neutropenia in rheumatoid arthritis: comparison with classical Felty's syndrome, Scand. J. Haematol., 33, 342–350.
   PubMedGoogle Scholar
• Platanias, L., Raefsky, E. and Youg, N. (1987). Neutropenia associated with large granular lymphocytes responsive to corticosteroids in vitro and in vivo, Eur. J. Haematol., 38, 89–94.
   PubMed Web of Science ®Google Scholar
• Thommsen, C., Nissen, C., Gratwohl, A., Tichelli, A. and Stern, A. (1989). Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), Br. J. Haematol., 71, 157–160.
   PubMed Web of Science ®Google Scholar
• Dale, D. C. and Hammond, W. P. (1988). Cyclic neutropenia, Blood. Rev., 2, 178–185.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr., Clark, E. A., Price, T. H. and Hammond, W. P. (1986). Adult onset cyclic neutropenia is associated with increased large granular lymphocytes, Blood, 68, 1082–1087.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr. and Hammond, W. P. (1986). Adult onset cyclic neutropenia is a benign neoplasm associated with clonal proliferation of large granular lymphocyte, J. Exp. Med., 164, 2089–2094.
   PubMed Web of Science ®Google Scholar
• Selleri, C., Catalano, L., Alfanito, F., De Rosa, G., Vaglio, S. and Rotoli, B. (1988). Cyclosporin A in adult-onset cyclic neutropenia, Br. J. Haematol., 68, 137–141.
   PubMed Web of Science ®Google Scholar
• Aprile, J. A., Russo, M., Pepe, M. S. and Loughran, T. P. Jr. (1991). Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes, Blood, 78, 1282–1285.
   PubMed Web of Science ®Google Scholar
• Spits, H., Yssel, H., Leeuwenberg, J. and De Vries, J. E. (1985). Antigen-specific cytotoxic T cell and antigenspecific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3, Eur. J. Immunol., 15, 88–91.
   PubMed Web of Science ®Google Scholar
• De Bruin, P. C., Kummer, A. J., van der Valk, P., Van Heerde, P., Kluin, P. M., Willenze, R., Ossenkopple, G. J., Radaszhiewicz, T. and Meijer, C. J. (1994). Granzyme-B-expressing peripheral T-cell lymphomas: Neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization, Blood, 84, 3785–3791.
   PubMed Web of Science ®Google Scholar
• Oshimi, K., Shinkai, Y., Okumura, K., Oshimi, Y. and Mizoguchi, H. (1990). Perforin gene expression in granular lymphocyte proliferative disorders, Blood, 75, 704–708.
   PubMed Web of Science ®Google Scholar
• Persova, R. and Loughran, T. P. Jr. (1997). Constitutive expression of Fas ligand in large granular lymphocytes leukaemia, Br. J. Haematol., 97, 123–126.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr., Coyle, T., Sherman, M. P., Starkebaum, G., Ehrlich, G. D., Ruscetti, F. W. and Poiesz, B. J. (1992). Detection of human T-cell leukemia/lymphoma virus, Type II in a patient with LGL leukemia, Blood, 80, 1116–1119.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr., Sherman, M. P., Ruscetti, F. W., Frey, S., Coyle, T., Montagna, R. A., Jones, B., Starkebaum, G. and Poiesz, B. J. (1994). Prototypical HTLV-I/II infection is rare in LGL leukemia, Leuk Research, 18, 423–429.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr., Hadlock, K. G., Yang, Q., Persova, R., Zambello, R., Semenzato, G., Foung, S. K. and Poiesz, B. J. (1997). Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients wtih CD3- (NK) lymphoproliferative disease of granular lymphocytes, Blood, 90, 1977–1981.
   PubMed Web of Science ®Google Scholar
• Loughran, T. P. Jr., Hadlock, K. G., Perzova, R., Gentile, T. C., Yang, Q., Foung, S. K. H. and Poiez, B. J. (1998). Epitope mapping of HTLV envelope seroreactivity in LGL leukemia, Br. J. Haematol., in press.
   Google Scholar
• Gentile, T. and Loughran, T. P. Jr. (1995). Interleukin-12 is a costimulatory cytokine for leukemic CD3+ large granular lymphocytes Cellular Immunol, 66, 158–161.
   Google Scholar
• Zambello, R., Trentin, L., Cassatella, M. A., Raimondi, R., Cerutti, A., Enthammer, C., Facco, M., Agostini, C., Semenzato, G. (1996). IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphorproliferative disease of granular lymphocytes, Br. J. Haematol., 92, 308–314.
   PubMed Web of Science ®Google Scholar
• Zambello, R., Facco, M., Trentin, L., Sancetta, R., Tassinari, C., Perin, A., Milani, A., Pizzolo, G., Rodeghiero, F., Agostini, C., Meazza, R., Ferrini, S. and Semenzato, G. (1997). Interleukin-15 triggers the proliferation and cytoxicity of granular lympochytes in patients with lymphoproliferative disease of granular lymphocytes, Blood, 89, 201–211.
   PubMed Web of Science ®Google Scholar
• Dhein, J., Walczak, H., Baumier, C., Debatin, K. M. and Krammer, P. H. (1995). Autocrine T -cell suicide mediated by APO-1 (Fas/CD95), Nature, 373, 438–441.
   PubMed Web of Science ®Google Scholar
• Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Rambsdell, F. and Lynch, D. H. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes, J. Exp. Med., 181, 71–77.
   PubMed Web of Science ®Google Scholar
• Glass, A., Walsh, C. M., Lynch, D. H. and Clarck, W. R. (1996). Regulation of the Fas lytic pathway in cloned CTL, J. Immunol., 156, 3638–3644.
   PubMed Web of Science ®Google Scholar
• Ortaldo, J. R., Winkler-Pickett, R. T., Nagata, S. and Ware, C. F. (1997). Fas involvement in human NK cell apoptosis: lack of a requirement for CD16-mediated events, J. Leucocyte. Biol., 61, 209–215.
   PubMed Web of Science ®Google Scholar
• Owen-Schaub, L. B., Yonehara, S., Crimp, W. L., and 3d, Grimm, E. A. (1992). DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement, Cell. Immunol., 140, 197–205.
   PubMed Web of Science ®Google Scholar
• Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. and Fergusson, T. A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189–1192.
   PubMed Web of Science ®Google Scholar
• Nagata, S. and Goldstein, O. (1995). The Fas death factor, Science, 267, 1449–1456.
   PubMed Web of Science ®Google Scholar
• Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Samashima, M., Hase, A., Seto, Y. and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell., 66, 233–243.
   PubMed Web of Science ®Google Scholar
• Nagata, S. (1997). Apoptotis by death factor, Cell, 88, 355–365.
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. (1992). Generalized lymphoproliferative disease in mice explained by defects in Fas antigen that mediates apoptosis, Nature, 356, 314–317.
   PubMed Web of Science ®Google Scholar
• Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. (1994). Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand, Cell, 76, 969–976.
   PubMed Web of Science ®Google Scholar
• Steinberg, A. D. (1994). MRL-1pr/1pr disease: theories meet Fas, Sem. Immunol, 6, 55–69.
   PubMedGoogle Scholar
• Cohen, P. L. and Eisenbert, R. A. (1992). The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane, Immunol. Today., 13, 427–428.
   PubMedGoogle Scholar
• Le Deist, F., Emile, J. F., Rieux-laucat, F., Benkerou, M., Roberts, I., Brousse, N. and Fisher, A. (1996). Clinical, immunological, and pathological consequences of Fasdeficient conditions, Lancet., 348, 719–723.
   PubMed Web of Science ®Google Scholar
• Fisher, G. H., Rosenberg, F. J., Strauss, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. and Puck, J. M. (1995). Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell, 81, 935–946.
   PubMed Web of Science ®Google Scholar
• Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J. L. and Elkon, K. B. (1996). Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity, N. Engl. J. Med., 335, 1643–1649.
   PubMed Web of Science ®Google Scholar
• Bettinardi, A., Brugnoni, D., Quiros-Roldan, E., Malagoli, A., La Grutta, S., Correra, A. and Notarangelo, L. D. (1997). Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis, Blood, 89, 902–909.
   PubMed Web of Science ®Google Scholar
• Sneller, M. C., Wang, J., Dale, J. K., Strober, W., Middleton, L. A., Choi, Y., Fleisher, T. A., Lim, M. S., Jaffe, E. S., Puck, J. M., Lenardo, M. J. and Straus, S. E. (1997). Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndorme associated with abnormal lymphocytes apoptosis, Blood, 89, 1341–1348.
   PubMed Web of Science ®Google Scholar
• Dianzani, U., Bragardo, M., DiFranco, D., Alliaudi, C., Scagni, P., Buonfiglio, D., Redoglia, V., Bonissoni, S., Correra, A., Dianzani, I. and Ramenghi, U. (1997). Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation, Blood, 89, 2871–2879.
   PubMed Web of Science ®Google Scholar
• Kneitz, B., Hermann, T., Yonehara, S. and Schimpl, A. (1995). Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2 deficient mice, Eur. J. Immunol., 25, 2572–2577.
   PubMed Web of Science ®Google Scholar
• Cascino, I., Fiucci, G., Papoff, G. and Ruberti, G. (1995). Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing, J. Immunol., 154, 2706–2713.
   PubMed Web of Science ®Google Scholar
• Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr., P. J. and Mountz, J. D. (1995). Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule, Science, 263, 1759–1762.
   Web of Science ®Google Scholar
• Hasunuma, T., Kayagaki, N., Asahara, H., Motokawa, S., Kobata, T., Yagita, H., Aono, H., Sumida, T., Okumura, K. and Nishioka, K. (1997). Accumulation of soluble Fas in inflammed joints of patients with rheumatoid arthritis, Arthritis Rheum., 40, 80–86.
   PubMed Web of Science ®Google Scholar
• Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H. and Nagata, S. (1996). Fas ligand in human serum, Nature Med., 2, 317–322.
   PubMed Web of Science ®Google Scholar
• Maciejewski, J., Selleri, C., Anderson, S. and Young, N. S (1995). Fas antigen expression on CD34+ human marrow cells is induced by interfer on γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro, Blood, 85, 3183–3190.
   PubMed Web of Science ®Google Scholar
• Takenaka, K., Nagafuji, K., Harada, M., Mizino, S. I., Miyamoto, T. Makino, S., Gondo, H., Okamura, T. and Niho, Y. (1996). In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95), Blood, 88, 2871–2877.
   PubMed Web of Science ®Google Scholar
• Iwai, K., Miyawaki, T., Takizawa, T., Kono, A., Ohta, K., Yachie, A., Seki, H. and Taniguchi, N. (1994). Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils, Blood, 84, 1201–1208.
   PubMed Web of Science ®Google Scholar
• Truman, J. P., Choqueux, C., Tschopp, J., Verdrenne, J., Le Deist, F., Charron, D. and Mooney, N. (1997). HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes, Blood, 89, 1996.
   PubMed Web of Science ®Google Scholar